HIGHLIGHTSFollowing an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review ...

Additional data analyses from Orbit and Cosmic Phase 3 studies of setrusumab (UX143) in osteogenesis imperfecta ongoing to determine potential path forward for the program ...

In power distribution systems, three-phase transformer configuration directly impacts system reliability and load management. Understanding the trade-offs between Delta and Wye connections enables ...

A major update about 28 Years Later 3 has come on the heels of the reactions around the upcoming sequel, 28 Years Later: The Bone Temple. With the series once again gaining momentum, fans now have a ...

Post-stroke complex regional pain syndrome (CRPS) is a challenging complication that impairs recovery during stroke rehabilitation, particularly during the subacute phase. Despite its clinical ...

Ultragenyx and Mereo Biopharma are expecting to report results from two phase 3 trials for Osteogenesis Imperfecta (OI), commonly known as brittle bone disease, at the end of 2025. Earlier in July, ...

The Defense Advanced Research Projects Agency (DARPA) Microsystems Technology Office awarded Northwestern Engineering’s Jie Gu and co-PIs Yiran Chen (Duke University) and Ramesh Harjani (University of ...

IgA nephropathy, the most common primary glomerulopathy worldwide, is a kidney disorder of B-cell origin characterized by mesangial accumulation of IgA-containing immune complexes. In at least 50% of ...

Complete Response in all treated lesions: Patients completing the study showed CR via the MD Anderson Criteria and RECIST v1.1 with no active tumor detected on MRI First-of-its-kind single ...

President Donald Trump this week said he recently underwent an MRI scan, but neither he nor his doctors provided any particular reason for undergoing the medical examination. Trump revealed he had the ...

Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved treatments, prompting the San Diego biotech to plot a submission to the FDA ...

More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and treated. By Paula Span Ronald Klein was biking around his neighborhood in ...